Previous Article | Next Article 
Journal of Clinical Microbiology, May 2007, p. 1637-1639, Vol. 45, No. 5
0095-1137/07/$08.00+0 doi:10.1128/JCM.00382-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Surveillance for Reassortant Virus by Multiplex Reverse Transcription-PCR Specific for Eight Genomic Segments of Avian Influenza A H5N1 Viruses
,
Prasert Auewarakul,1
Kantima Sangsiriwut,1
Kridsda Chaichoune,2
Arunee Thitithanyanont,3
Witthawat Wiriyarat,2
Taweesak Songserm,4
Rasameepen Ponak-nguen,2
Jarunee Prasertsopon,1
Phisanu Pooruk,1
Pathom Sawanpanyalert,5
Parntep Ratanakorn,2 and
Pilaipan Puthavathana1*
Department of Microbiology, Faculty of Medicine, Siriraj Hospital, Bangkok,1
Faculty of Veterinary Science, Nakhon Pathom,2
Faculty of Science, Bangkok,3
Mahidol University, Faculty of Veterinary Medicine, Kasetsart University, Nakhon Pathom,4
Department of Medical Sciences, Ministry of Public Health, Nonthaburi, Thailand5
Received 19 February 2007/
Returned for modification 23 February 2007/
Accepted 14 March 2007

ABSTRACT
Avian influenza H5N1 virus is a global threat. An emergence
of a reassortant virus with a pandemic potential is a major
concern. Here we describe a multiplex reverse transcription-PCR
assay that is specific for the eight genomic segments of the
currently circulating H5N1 viruses to facilitate surveillance
for a virus resulting from reassortment between human influenza
virus and the H5N1 virus.

TEXT
The genome of influenza A viruses is composed of eight gene
segments, which encode polymerase (PB1, PB2, and PA), nucleocapsid
(NP), hemagglutinin (HA), neuraminidase (NA), matrix (M) protein,
and nonstructural (NS) protein. Since influenza viruses have
segmented genomes, they are able to evolve through reassortment
(
1). Both the 1957 and 1968 pandemic strains are believed to
be reassortants in which HA and PB1 genes, with or without the
NA gene, were replaced by the corresponding genomic segments
of avian influenza virus strains (
5). The reassortments provided
the viruses with new HA and NA antigenic profiles and the ability
to spread efficiently from human to human. The ongoing outbreak
of the highly virulent avian influenza virus H5N1 is concerning
because of the possibility of a reassortant virus emerging with
pandemic potential (
3). Monitoring for a reassortant with mixed
genomic segments from human and avian viruses is therefore very
important. However, detection of a reassortant requires sequencing
of all eight genomic segments, a process which is laborious
and time consuming. Therefore, we developed a simple and high-throughput
screening method using multiplex reverse transcription-PCR (RT-PCR)
specific for eight genomic segments of recent H5N1 viruses to
detect the probable reassortant viruses worthy of further characterization.
For the primer design, 100 full-length sequences arbitrarily selected from the Influenza Virus Resource Database (National Center for Biotechnology Information; http://www.ncbi.nlm.nih.gov/genomes/FLU/) were used to search for the sequence(s) that was conserved in H5N1 and that differed from those of other subtypes. The viruses used in this study comprised 28 human influenza virus isolates and 103 H5N1 isolates from various animal species (94 isolates from poultry and other birds, 6 isolates from tigers, 2 isolates from leopards, and 1 isolate from a cat). These viruses have been collected since the beginning of the epidemic in the country. In 2003, 2004, 2005, and 2006, 7, 34, 60, and 2 animal H5N1 virus isolates were collected, respectively. The human viruses comprised 6 H5N1, 3 H1N1, 8 H3N2, and 11 influenza B viruses. These viruses were propagated in MDCK cells or embryonated eggs. The H5N1 viruses were originally subtyped by RT-PCR. The subtyping was confirmed by sequencing for all human H5 and some animal H5 viruses (2). Available accession numbers of some of the H5N1 virus isolates used in this study are shown in Table S1 in the supplemental material and also in a report by Puthavathana et al. (4). The human H1, H3, and influenza B viruses were characterized and confirmed with respect to their subtypes by hemagglutination inhibition assay at the WHO Reference Laboratories, Melbourne, Australia, or the Centers for Disease Control and Prevention of the United States via the National Reference Laboratory on Influenza, NIH, Thailand.
RNA was extracted by using a QIAamp viral RNA Mini kit (QIAGEN, Valencia, CA). A 140-µl volume of virus suspension from the infected culture or embryonated egg yielded a volume of 60 µl of extracted RNA. Multiplex RT-PCR was carried out in three reaction tubes with combinations of the following primer sets: NA plus PB1 plus NP, HA plus PA plus PB2, or NS plus M. Sequences of these primers are shown in Table 1. The thermocycling was performed in a GeneAmp PCR system 2400 thermal cycler (Perkin Elmer) using a QIAGEN OneStep RT-PCR kit (QIAGEN, Valencia, CA) with standard reaction conditions (a 50 µl volume containing 1x PCR buffer, 5 to 10 µl of extracted RNA, 400 µM (each) deoxynucleoside triphosphate, 2.5 mM MgCl2, 2 µl enzyme mix, and 2 U RNase inhibitor). The thermocycling profile was 50°C for 30 min, 95°C for 15 min, 35 cycles of 95°C for 45 s, 55°C for 45 s, and 72°C for 45 s, and a final extension of 72°C for 10 min. The PCR products were visualized by ethidium bromide staining after electrophoresis in a 2% agarose gel.
View this table:
[in this window]
[in a new window]
|
TABLE 1. Sequences, concentrations used in the reaction, nucleotide positions, and product sizes of PCR primers for the eight gene segments
|
In our multiplex RT-PCR assay, potential reassortants would
show the lack of one or more of the eight amplicons in the case
of H5N1 viruses and the presence of one or more amplicons in
the case of H1N1 and H3N2 viruses. With the designed primer
set, we could initially amplify all eight genomic segments from
105 out of 109 H5N1 viruses. Four viruses initially gave negative
amplification results for NA. However, these four viruses yielded
positive NA band results in separated single-gene amplifications,
and multiplex reamplification using 1.5- to 2-fold-higher RNA
input gave positive amplification results for all genes. Representative
results obtained with the multiplex RT-PCR products are shown
in Fig.
1. None of the human H3N2, H1N1, or influenza B virus
isolates yielded any amplification products by this method (data
not shown). In order to verify the lack of reassortment, all
human H5N1 viruses and a subset of animal viruses (62 out of
103) were subjected to a full-genome sequencing protocol as
previously described (
4). Phylogenetic analyses of the sequence
data revealed that all viruses contained their respective genomic
segments and that no evidence of reassortment was found (data
not shown). In addition to detecting human-avian virus reassortants,
our assay may also be able to detect some reassortants that
acquire genomic segments from some other unrelated avian viruses.
However, the assay was not designed to detect reassortment among
avian viruses, which are unlikely to play a role in viral adaptation
to the human host. The absence of a band in the amplification
of H5N1 viruses is not always due to reassortment. Full-genome
sequencing is needed for result confirmation. Because the performance
of this assay is directly affected by variation in the sequences
of circulating H5N1 strains, the primer sequences should be
frequently reevaluated and updated accordingly.
Our multiplex RT-PCR was designed for egg- or MDCK-propagated
viruses. Although the assay may be able to detect some of the
genes in some clinical specimens, the level of sensitivity is
probably not sufficient to reliably detect all the genomic segments
simultaneously. This makes our assay less suitable for direct
screening using clinical specimens. Nevertheless, the possibility
of using a more sensitive version of this assay with clinical
specimens should be further explored.

ACKNOWLEDGMENTS
This study was supported by research grants from the National
Center for Genetic Engineering and Biotechnology and the Thailand
Research Fund for Advanced Research Scholar.
We thank Darat Lauhakirti and Sirawat Srichatrapimuk for their collaboration in the preparation of the manuscript.

FOOTNOTES
* Corresponding author. Mailing address: Department of Microbiology, Faculty of Medicine, Siriraj Hospital, Mahidol University, 2 Prannok Road, Bangkok Noi, Bangkok 10700, Thailand. Phone: 662 419 7059. Fax: 662 418 4148. E-mail:
siput{at}mahidol.ac.th 
Supplemental material for this article may be found at http://jcm.asm.org/. 
Published ahead of print on 21 March 2007. 

REFERENCES
1 - Guan, Y., J. S. Peiris, A. S. Lipatov, T. M. Ellis, K. C. Dyrting, S. Krauss, L. J. Zhang, R. G. Webster, and K. F. Shortridge. 2002. Emergence of multiple genotypes of H5N1 avian influenza viruses in Hong Kong SAR. Proc. Natl. Acad. Sci. USA 99:8950-8955.[Abstract/Free Full Text]
2 - Hoffmann, E., J. Stech, Y. Guan, and R. G. Webster. 2001. Universal primer set for the full-length amplification of all influenza viruses. Arch. Virol. 146:2275-2289.[CrossRef][Medline]
3 - Li, K. S., Y. Guan, J. Wang, G. J. Smith, K. M. Xu, L. Duan, A. P. Rahardjo, P. Puthavathana, C. Buranathai, T. D. Nguyen, A. T. Estoepangestie, A. Chaisingh, P. Auewarakul, H. T. Long, N. T. Hanh, R. J. Webby, L. L. Poon, H. Chen, K. F. Shortridge, K. Y. Yuen, R. G. Webster, and J. S. Peiris. 2004. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature 430:209-213.[CrossRef][Medline]
4 - Puthavathana, P., P. Auewarakul, P. C. Charoenying, K. Sangsiriwut, P. Pooruk, K. Boonnak, R. Khanyok, P. Thawachsupa, R. Kijphati, and P. Sawanpanyalert. 2005. Molecular characterization of the complete genome of human influenza H5N1 virus isolates from Thailand. J. Gen. Virol. 86:423-433.[Abstract/Free Full Text]
5 - Webster, R. G., W. J. Bean, O. T. Gorman, T. M. Chambers, and Y. Kawaoka. 1992. Evolution and ecology of influenza A viruses. Microbiol. Rev. 56:152-179.[Abstract/Free Full Text]
Journal of Clinical Microbiology, May 2007, p. 1637-1639, Vol. 45, No. 5
0095-1137/07/$08.00+0 doi:10.1128/JCM.00382-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.